UnitedHealth Group (NYSE:UNH) had its target price lifted by BMO Capital Markets from $14.50 to $275.00 in a research report report published on Wednesday morning. The brokerage currently has an outperform rating on the healthcare conglomerate’s stock.

Other analysts have also recently issued reports about the company. Piper Jaffray Companies reissued a buy rating and issued a $259.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Royal Bank of Canada upped their target price on UnitedHealth Group from $269.00 to $280.00 and gave the company an outperform rating in a research report on Wednesday. Wells Fargo & Co reaffirmed an outperform rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Leerink Swann reaffirmed an outperform rating on shares of UnitedHealth Group in a research report on Friday, December 1st. Finally, Citigroup increased their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the stock a buy rating in a research report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $241.30.

Shares of UnitedHealth Group (NYSE:UNH) traded up $4.73 during midday trading on Wednesday, hitting $243.16. The company had a trading volume of 6,233,080 shares, compared to its average volume of 2,990,000. The firm has a market cap of $235,100.00, a PE ratio of 22.70, a PEG ratio of 1.48 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group has a 1 year low of $156.09 and a 1 year high of $243.90.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.79% and a net margin of 5.25%. The business’s revenue was up 9.5% on a year-over-year basis. During the same period in the prior year, the firm earned $2.11 EPS. research analysts forecast that UnitedHealth Group will post 11.66 EPS for the current year.

In other news, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now directly owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. Insiders sold a total of 33,655 shares of company stock valued at $7,469,083 over the last three months. Insiders own 0.89% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Regal Wealth Group Inc. lifted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after buying an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. increased its stake in UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares in the last quarter. RNC Capital Management LLC increased its stake in UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares in the last quarter. Highland Private Wealth Management increased its stake in UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares in the last quarter. Finally, Flagship Harbor Advisors LLC increased its stake in UnitedHealth Group by 0.3% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 5,028 shares of the healthcare conglomerate’s stock valued at $939,000 after purchasing an additional 15 shares in the last quarter. 86.09% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “BMO Capital Markets Increases UnitedHealth Group (UNH) Price Target to $275.00” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/bmo-capital-markets-increases-unitedhealth-group-unh-price-target-to-275-00/1812923.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.